Oyster Point Pharma Inc (OYST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 128,630 | 139,147 | 72,278 | 83,357 | N/A |
| TOTAL | $131,018 | $142,180 | $76,895 | $87,410 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 263 | 181 | N/A | N/A | N/A |
| Other Non-Current Assets | 1,031 | 848 | 3,181 | 477 | 0 |
| TOTAL | $1,294 | $1,029 | $3,181 | $477 | $N/A |
| Total Assets | $132,312 | $143,209 | $80,076 | $87,887 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,891 | 507 | 1,833 | 2,090 | 0 |
| Accrued Expenses | 2,483 | 4,596 | 3,458 | 1,419 | N/A |
| TOTAL | $9,765 | $5,399 | $5,579 | $3,545 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 584 | 512 | 136,447 | 135,853 | 0 |
| TOTAL | $584 | $512 | $136,447 | $135,853 | $N/A |
| Total Liabilities | $10,349 | $5,911 | $142,026 | $139,398 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 21,380 | 21,367 | 21,363 | 20,612 | N/A |
| Common Shares | 21 | 21 | 1 | 1 | N/A |
| Retained earnings | -100,750 | -84,231 | -64,507 | -53,010 | N/A |
| TOTAL | $121,963 | $137,298 | $-61,950 | $-51,511 | $N/A |
| Total Liabilities And Equity | $132,312 | $143,209 | $80,076 | $87,887 | $0 |